Invitation to presentation of Mendus’ year-end report for 2023

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
 Invitation to presentation of Mendus’ year-end report for 2023
 8:00:00 AM

Keep reading
Mendus announces ethics committee approval for the AMLM22-CADENCE trial with lead product vididencel in AMLRead